CYP20A1
Basic information
Region (hg38): 2:203238977-203306026
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CYP20A1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 24 | 26 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 24 | 0 | 2 |
Variants in CYP20A1
This is a list of pathogenic ClinVar variants found in the CYP20A1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
2-203239133-C-A | not specified | Uncertain significance (Jul 12, 2022) | ||
2-203245892-A-C | not specified | Uncertain significance (Nov 21, 2022) | ||
2-203246800-G-T | not specified | Uncertain significance (Feb 28, 2023) | ||
2-203246805-T-A | not specified | Uncertain significance (Jun 07, 2023) | ||
2-203246815-G-T | not specified | Uncertain significance (Sep 20, 2023) | ||
2-203246825-T-G | not specified | Uncertain significance (Oct 03, 2022) | ||
2-203246832-C-T | not specified | Uncertain significance (Jan 04, 2024) | ||
2-203246858-C-T | not specified | Uncertain significance (Aug 30, 2022) | ||
2-203246907-A-G | not specified | Uncertain significance (Jul 06, 2021) | ||
2-203252041-A-G | not specified | Uncertain significance (Sep 16, 2021) | ||
2-203266631-A-C | not specified | Uncertain significance (Jun 10, 2022) | ||
2-203272692-G-C | not specified | Uncertain significance (Feb 23, 2023) | ||
2-203272727-C-T | not specified | Uncertain significance (Jan 03, 2024) | ||
2-203278629-A-G | not specified | Uncertain significance (Oct 06, 2022) | ||
2-203278642-A-G | not specified | Uncertain significance (Dec 28, 2022) | ||
2-203278682-C-A | not specified | Uncertain significance (Apr 04, 2024) | ||
2-203280101-A-G | not specified | Uncertain significance (Jan 02, 2024) | ||
2-203285687-T-C | not specified | Uncertain significance (Jan 04, 2022) | ||
2-203285729-T-C | not specified | Uncertain significance (Jun 10, 2024) | ||
2-203289791-C-G | not specified | Uncertain significance (Jun 04, 2024) | ||
2-203289835-G-A | not specified | Uncertain significance (Oct 29, 2021) | ||
2-203289852-T-G | Benign (Apr 19, 2018) | |||
2-203292271-C-T | not specified | Uncertain significance (May 31, 2024) | ||
2-203292283-G-T | not specified | Uncertain significance (Aug 28, 2023) | ||
2-203292284-G-A | not specified | Uncertain significance (Oct 27, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CYP20A1 | protein_coding | protein_coding | ENST00000356079 | 13 | 59347 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
8.89e-17 | 0.00900 | 125647 | 0 | 100 | 125747 | 0.000398 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.375 | 215 | 231 | 0.931 | 0.0000109 | 3011 |
Missense in Polyphen | 47 | 55.416 | 0.84813 | 715 | ||
Synonymous | 0.230 | 79 | 81.6 | 0.968 | 0.00000379 | 860 |
Loss of Function | 0.103 | 25 | 25.6 | 0.978 | 0.00000132 | 319 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000761 | 0.000682 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000388 | 0.000381 |
Finnish | 0.000140 | 0.000139 |
European (Non-Finnish) | 0.000440 | 0.000422 |
Middle Eastern | 0.000388 | 0.000381 |
South Asian | 0.000849 | 0.000817 |
Other | 0.000547 | 0.000326 |
dbNSFP
Source:
- Pathway
- Oxidation by Cytochrome P450;Metapathway biotransformation Phase I and II
(Consensus)
Recessive Scores
- pRec
- 0.205
Intolerance Scores
- loftool
- 0.865
- rvis_EVS
- 0.26
- rvis_percentile_EVS
- 70.52
Haploinsufficiency Scores
- pHI
- 0.171
- hipred
- N
- hipred_score
- 0.216
- ghis
- 0.467
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.0473
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | High | Medium | High |
Cancer | High | High | High |
Mouse Genome Informatics
- Gene name
- Cyp20a1
- Phenotype
- adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); growth/size/body region phenotype;
Zebrafish Information Network
- Gene name
- cyp20a1
- Affected structure
- whole organism
- Phenotype tag
- abnormal
- Phenotype quality
- increased behavioural activity
Gene ontology
- Biological process
- oxidation-reduction process
- Cellular component
- membrane;integral component of membrane
- Molecular function
- monooxygenase activity;iron ion binding;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;heme binding